Sopharma Trading AD Past Earnings Performance
Past criteria checks 5/6
Sopharma Trading AD has been growing earnings at an average annual rate of 14.5%, while the Healthcare industry saw earnings growing at 12.2% annually. Revenues have been growing at an average rate of 13.5% per year. Sopharma Trading AD's return on equity is 24.2%, and it has net margins of 1.8%.
Key information
14.5%
Earnings growth rate
14.1%
EPS growth rate
| Healthcare Industry Growth | 13.4% |
| Revenue growth rate | 13.5% |
| Return on equity | 24.2% |
| Net Margin | 1.8% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
We're Not Counting On Sopharma Trading AD (BUL:SO5) To Sustain Its Statutory Profitability
Feb 14
If You Had Bought Sopharma Trading AD's (BUL:SO5) Shares Three Years Ago You Would Be Down 27%
Dec 18We Wouldn't Rely On Sopharma Trading AD's (BUL:SO5) Statutory Earnings As A Guide
Aug 10
Sopharma Trading AD's (BUL:SO5) Shareholders Are Down 35% On Their Shares
Jul 20Revenue & Expenses BreakdownBeta
How Sopharma Trading AD makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 1,678 | 30 | 116 | 0 |
| 30 Sep 23 | 1,615 | 9 | 111 | 0 |
| 30 Jun 23 | 1,583 | 12 | 107 | 0 |
| 31 Mar 23 | 1,530 | 10 | 104 | 0 |
| 31 Dec 22 | 1,483 | 9 | 101 | 0 |
| 30 Sep 22 | 1,438 | 21 | 101 | 0 |
| 30 Jun 22 | 1,412 | 18 | 100 | 0 |
| 31 Mar 22 | 1,378 | 13 | 99 | 0 |
| 31 Dec 21 | 1,336 | 8 | 98 | 0 |
| 30 Sep 21 | 1,333 | 15 | 97 | 0 |
| 30 Jun 21 | 1,269 | 12 | 88 | 0 |
| 31 Mar 21 | 1,190 | 12 | 79 | 0 |
| 31 Dec 20 | 1,156 | 11 | 72 | 0 |
| 30 Sep 20 | 1,068 | 10 | 64 | 0 |
| 30 Jun 20 | 1,017 | 10 | 64 | 0 |
| 31 Mar 20 | 1,002 | 11 | 65 | 0 |
| 31 Dec 19 | 946 | 9 | 63 | 0 |
| 30 Sep 19 | 929 | 8 | 62 | 0 |
| 30 Jun 19 | 916 | 9 | 61 | 0 |
| 31 Mar 19 | 901 | 9 | 61 | 0 |
| 31 Dec 18 | 888 | 9 | 61 | 0 |
| 30 Sep 18 | 866 | 8 | 61 | 0 |
| 30 Jun 18 | 825 | 8 | 60 | 0 |
| 31 Mar 18 | 776 | 8 | 57 | 0 |
| 31 Dec 17 | 721 | 9 | 54 | 0 |
| 30 Sep 17 | 669 | 10 | 50 | 0 |
| 30 Jun 17 | 642 | 10 | 46 | 0 |
| 31 Mar 17 | 626 | 11 | 45 | 0 |
| 31 Dec 16 | 613 | 11 | 42 | 0 |
| 30 Sep 16 | 602 | 10 | 41 | 0 |
| 30 Jun 16 | 604 | 11 | 40 | 0 |
| 31 Mar 16 | 603 | 11 | 39 | 0 |
| 31 Dec 15 | 603 | 11 | 38 | 0 |
| 30 Sep 15 | 598 | 12 | 37 | 0 |
| 30 Jun 15 | 587 | 11 | 34 | 0 |
| 31 Dec 14 | 576 | 11 | 32 | 0 |
| 30 Sep 14 | 566 | 12 | 31 | 0 |
| 30 Jun 14 | 550 | 12 | 30 | 0 |
| 31 Mar 14 | 529 | 11 | 29 | 0 |
| 31 Dec 13 | 507 | 9 | 29 | 0 |
| 30 Sep 13 | 494 | 10 | 28 | 0 |
| 30 Jun 13 | 480 | 9 | 28 | 0 |
Quality Earnings: SFT has high quality earnings.
Growing Profit Margin: SFT's current net profit margins (1.8%) are higher than last year (0.6%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: SFT's earnings have grown by 14.5% per year over the past 5 years.
Accelerating Growth: SFT's earnings growth over the past year (230.7%) exceeds its 5-year average (14.5% per year).
Earnings vs Industry: SFT earnings growth over the past year (230.7%) exceeded the Healthcare industry 2%.
Return on Equity
High ROE: Whilst SFT's Return on Equity (24.21%) is high, this metric is skewed due to their high level of debt.